Yardena Samuels
- Molecular Biology top 0.5%
- Oncology top 0.2%
- Cancer Research top 0.5%
- Immunology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Victor E. VelculescuBert VogelsteinKenneth W. KinzlerSteve SzaboNatalie SillimanJanine PtakSteven A. RosenbergHai Yan
- Topics
- Melanoma and MAPK Pathways (19 papers)Immunotherapy and Immune Responses (15 papers)PI3K/AKT/mTOR signaling in cancer (14 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Yardena Samuels
78 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 8.0k
- Oncology 5.0k
- Cancer Research 2.3k
- Immunology 2.1k
- Pulmonary and Respiratory Medicine 1.7k
Countries citing papers authored by Yardena Samuels
This map shows the geographic impact of Yardena Samuels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yardena Samuels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yardena Samuels more than expected).
Fields of papers citing papers by Yardena Samuels
This network shows the impact of papers produced by Yardena Samuels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yardena Samuels. The network helps show where Yardena Samuels may publish in the future.
Co-authorship network of co-authors of Yardena Samuels
This figure shows the co-authorship network connecting the top 25 collaborators of Yardena Samuels. A scholar is included among the top collaborators of Yardena Samuels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yardena Samuels. Yardena Samuels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 67 | |
| 3 | 11 | |
| 4 | 28 | |
| 5 | 14 | |
| 6 | 2 | |
| 7 | 34 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 41 | |
| 11 | 304 | |
| 12 | 8 | |
| 13 | 311 | |
| 14 | 41 | |
| 15 | 106 | |
| 16 | 102 | |
| 17 | 446 | |
| 18 | 415 | |
| 19 | Mutant PIK3CA promotes cell growth and invasion of human cancer cellsbreakdown → | 727 |
| 20 | High Frequency of Mutations of the PIK3CA Gene in Human Cancersbreakdown → | 2708 |
About Yardena Samuels
Yardena Samuels is a scholar working on Oncology, Immunology and Allergy and Cancer Research, having authored 78 papers that have together received 11.7k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (19 papers), Immunotherapy and Immune Responses (15 papers) and PI3K/AKT/mTOR signaling in cancer (14 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (2.3k citations) and Genetics (1.3k citations). Yardena Samuels has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Victor E. Velculescu, Bert Vogelstein, Kenneth W. Kinzler, Steve Szabo, Natalie Silliman, Janine Ptak, Steven A. Rosenberg, Hai Yan, Kajsa Ericson and Alberto Bardelli. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.